Avecia boosts biocatalysis R&D

- Last updated on GMT

Related tags: Pharmaceutical drug, Avecia

UK-based Avecia, Europe's largest privately owned chemicals
company, has teamed up with Germany's IEP to develop new synthetic
routes for pharmaceutical intermediates using biocatalysis.

The agreement also represents a bolstering of Avecia's activities in chiral production technology, which has developed rapidly in the last few years due to an increasing demand for chiral or single stereoisomer compounds as active ingredients in pharmaceuticals. Chiral ingredients are those that consist of just one of the two mirror-image conformations that are encountered in organic compounds.

Reduction of compounds such as ketones is a key stage in the synthesis of a number of chiral intermediates, and there is a growing movement towards the use of biocatalysts for this purpose, with new collaborations in this area between DSM and Degussa and Wacker and Prokaria, amongst others.

Under the terms of the alliance, IEP​ will perform development work for Avecia​ on various unnamed pharmaceutical intermediates, and the two companies will combine their biocatalysis process technology to develop improved bioreduction processes to produce the target compounds. Financial details were not disclosed.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars